Boston Scientific (BSX) exec says goal is flat pricing each year, but flat to down 1% is what to expect on go forward basis - JPM conference

Boston Scientific's executive comments suggest a cautious outlook on pricing stability, with expectations for flat to slightly declining revenue in the near term.

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

Venezuela reportedly starts reversing oil output cuts as exports resume, according to reports

US lawmakers reportedly move again to revive Trump-supported credit card competition bill (CCCA)

Boston Scientific (BSX) exec says goal is flat pricing each year, but flat to down 1% is what to expect on go forward basis - JPM conference

Upside in Churchill Capital (CCCX) attributed to touted deal with Dell Technnologies (DELL) via post from Infleqtion on LinkedIn

JPMorgan (JPM) and Citi (C) reportedly in talks to finance USD 1bln Argentina gas pipeline

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Exec says China won't grow 20% like it used to, but confident it will grow in teens going forward.
Context

This realism about growth prospects, particularly in key markets like China, may signal challenges ahead for the company's margins and could influence investor sentiment regarding the stock's short-term performance.

Related headlines

The whole workspace, free to try.

Try it free